AEYE is up +392.76% since Feb ’24 pick Unlock All Top Buy Picks
RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ETNB
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Green day on Monday for 89bio, Inc.
(Updated on May 20, 2024)

Sell candidate since May 16, 2024 Loss -0.33% PDF

The 89bio, Inc. stock price gained 3.59% on the last trading day (Monday, 20th May 2024), rising from $8.63 to $8.94. During the last trading day the stock fluctuated 6.93% from a day low at $8.51 to a day high of $9.10. The price has fallen in 6 of the last 10 days and is down by -6.78% for this period. Volume fell on the last day by -303 thousand shares and in total, 485 thousand shares were bought and sold for approximately $4.34 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -30.47% during the next 3 months and, with a 90% probability hold a price between $4.90 and $6.93 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ETNB Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, April 25, 2024, and so far it has risen 8.36%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The 89bio, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $9.36. On a fall, the stock will find some support from the short-term average at $8.89. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.

Support, Risk & Stop-loss for 89bio, Inc. stock

89bio, Inc. finds support from accumulated volume at $8.70 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.590 between high and low, or 6.93%. For the last week, the stock has had daily average volatility of 5.05%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ETNB) For The Upcoming Trading Day Of Tuesday 21st

For the upcoming trading day on Tuesday, 21st we expect 89bio, Inc. to open at $8.85, and during the day (based on 14 day Average True Range), to move between $8.43 and $9.45, which gives a possible trading interval of +/-$0.513 (+/-5.74%) up or down from last closing price. If 89bio, Inc. takes out the full calculated possible swing range there will be an estimated 11.49% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $8.70 (2.68%) than the resistance at $9.37 (4.81%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is 89bio, Inc. stock A Buy?

89bio, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.876 Sell Candidate Unchanged

Predicted Opening Price for 89bio, Inc. of Tuesday, May 21, 2024

Fair opening price May 21, 2024 Current price
$8.85 ( 1.01%) $8.94

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ETNB

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 9.44 5.59 %
R2 9.21 3.07 %
R1 9.08 1.51 %
Current price: 8.94
Support S1 8.62 -3.53 %
S2 8.49 -5.09 %
S3 8.26 -7.61 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 11.03 23.38 %
R2 10.59 18.46 %
R1 9.37 4.81 %
Current price 8.94
Support S1 8.70 -2.68%
S2 8.58 -4.03%
S3 8.25 -7.72%

FAQ

What is the symbol for 89bio, Inc. Stock and on which exchange is it traded?
The symbol for 89bio, Inc. is ETNB and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell 89bio, Inc. Stock?
89bio, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy 89bio, Inc. Stock?
89bio, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy 89bio, Inc. Stock.

What's the current price of 89bio, Inc. Stock?
As of the end of day on the May 20, 2024, the price of an 89bio, Inc. (ETNB) share was $8.94.

What is the 52-week high and low for 89bio, Inc. Stock?
The 52-week high for 89bio, Inc. Stock is $22.93 and the 52-week low is $6.58.

What is the market capitalization of 89bio, Inc. Stock?
As of the May 20, 2024, the market capitalization of 89bio, Inc. is 879.553M.

When is the next earnings date for 89bio, Inc.?
The upcoming earnings date for 89bio, Inc. is Aug 14, 2024.
Click to get the best stock tips daily for free!

About 89bio, Inc.

89bio. 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also intends to develop pegozafermin for the treatment of severe hypertriglyceridemia. 89bio, Inc. was incorpor... ETNB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT